Skip to main content
Clinical Trials/IRCT20231002059591N1
IRCT20231002059591N1
Not yet recruiting
Phase 4

Comparing the effectiveness of the combination of atorvastatin and aspirin with atorvastatin alone on the severity of liver fibrosis in cirrhotic patients referred to Ali Bin Abi Taleb Hospital in2023-2025

Zahedan University of Medical Sciences0 sites81 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Zahedan University of Medical Sciences
Enrollment
81
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zahedan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with liver cirrhosis who were diagnosed with symptoms
  • Ultrasound based on cirrhosis

Exclusion Criteria

  • pregnant woman
  • Statin use in the last year
  • affected hcc
  • Myopathy caused by atherostatin treatment
  • child pugh\>13
  • Evidence of infection in the last 4 weeks
  • Hepatornal syndrome in clinical and biochemical evidence in the last 14 days
  • High hepatic encephalopathy 2
  • 3 times increase of aminotransferase in 3 months after starting the study
  • Recent use of febrate, varithromycin and others

Outcomes

Primary Outcomes

Not specified

Similar Trials